Showing results (241-250 of 8,520) with videos related to

Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|June 10, 2005
Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsiaM Kato, M Watanabe, S Konishi, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2005
Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsiaY Kinoshita, T Hashimoto, A Kawamura, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2005
Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcerT Kamada, J Hata, H Kusunoki, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2005
A nationwide study of the incidence and 30-day mortality rate of pyogenic liver abscess in Denmark, 1977-2002P Jepsen, H Vilstrup, H C Schønheyder, et al.
Alimentary Pharmacology & Therapeutics|May 11, 2005
7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failureJ P Gisbert, J Fuentes, D Carpio, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2005
Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer diseaseT Kamada, J Hata, H Kusunoki, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2005
Human leucocyte antigen determinants of susceptibility to Barrett's oesophagus in Asians--a preliminary studyS Rajendra, R Ackroyd, S Murad, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2005
Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesisP R Gibson, S J Shepherd
Alimentary Pharmacology & Therapeutics|June 14, 2005
Gender and liver fibrosis in chronic hepatitis: the role of iron statusC Rigamonti, S Andorno, E Maduli, et al.
Pageof 852